{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:12:41Z","timestamp":1776802361429,"version":"3.51.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant bone disease (MBD) occurs when tumors establish in bone, causing catastrophic tissue damage as a result of accelerated bone destruction and inhibition of repair. The resultant so-called osteolytic lesions (OL) take the form of tumor-filled cavities in bone that cause pain, fractures, and associated morbidity. Furthermore, the OL microenvironment can support survival of tumor cells and resistance to chemotherapy. Therefore, a deeper understanding of OL formation and MBD progression is imperative for the development of future therapeutic strategies. Herein, we describe a novel in vitro platform to study bone\u2013tumor interactions based on three-dimensional co-culture of osteogenically enhanced human mesenchymal stem cells (OEhMSCs) in a rotating wall vessel bioreactor (RWV) while attached to micro-carrier beads\u00a0coated with extracellular matrix (ECM) composed of factors found in anabolic bone tissue. Osteoinhibition was recapitulated in this model by co-culturing the OEhMSCs with a bone\u2013tumor cell line (MOSJ-Dkk1) that secretes the canonical Wnt (cWnt) inhibitor Dkk-1, a tumor-borne osteoinhibitory factor widely associated with several forms of MBD, or intact tumor fragments from Dkk-1 positive patient-derived xenografts (PDX). Using the model, we observed that depending on the conditions of growth, tumor cells can biochemically inhibit osteogenesis by disrupting cWnt activity in OEhMSCs, while simultaneously co-engrafting with OEhMSCs, displacing them from the niche, perturbing their activity, and promoting cell death. In the absence of detectable co-engraftment with OEhMSCs, Dkk-1 positive PDX fragments had the capacity to enhance OEhMSC proliferation while inhibiting their osteogenic differentiation. The model described has the capacity to provide new and quantifiable insights into the multiple pathological mechanisms of MBD that are not readily measured using monolayer culture or animal models.<\/jats:p>","DOI":"10.1038\/s41419-018-1203-8","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T10:52:37Z","timestamp":1543229557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibition"],"prefix":"10.1038","volume":"9","author":[{"given":"Eoin P.","family":"McNeill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abishek","family":"Tondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bret H.","family":"Clough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah","family":"Froese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Kaunas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl A.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"1203_CR1","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman, G. D. Mechanisms of bone metastasis. N. Engl. J. Med. 350, 1655\u20131664 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1203_CR2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad, F. et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110, 1860\u20131867 (2007).","journal-title":"Cancer"},{"key":"1203_CR3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1634\/stemcells.2005-0220","volume":"24","author":"WG Gunn","year":"2006","unstructured":"Gunn, W. G. et al. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 24, 986\u2013991 (2006).","journal-title":"Stem Cells"},{"key":"1203_CR4","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1158\/0008-5472.CAN-11-2067","volume":"72","author":"JA Fowler","year":"2012","unstructured":"Fowler, J. A., Mundy, G. R., Lwin, S. T. & Edwards, C. M. Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for wnt inhibitor dkk1. Cancer Res. 72, 2183\u20132189 (2012).","journal-title":"Cancer Res."},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1182\/blood-2007-03-077685","volume":"111","author":"CM Edwards","year":"2008","unstructured":"Edwards, C. M. et al. Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo. Blood 111, 2833\u20132842 (2008).","journal-title":"Blood"},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/sj.leu.2404466","volume":"21","author":"B Arnulf","year":"2007","unstructured":"Arnulf, B. et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia 21, 158\u2013163 (2007).","journal-title":"Leukemia"},{"key":"1203_CR7","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1080\/10428190701593644","volume":"48","author":"L Garderet","year":"2007","unstructured":"Garderet, L. et al. Mesenchymal stem cell abnormalities in patients with multiple myeloma. Leuk. Lymphoma 48, 2032\u20132041 (2007).","journal-title":"Leuk. Lymphoma"},{"key":"1203_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","volume":"97","author":"N Voorzanger-Rousselot","year":"2007","unstructured":"Voorzanger-Rousselot, N. et al. Increased Dickkopf-1 expression in breast cancer bone metastases. Br. J. Cancer 97, 964\u2013970 (2007).","journal-title":"Br. J. Cancer"},{"key":"1203_CR9","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian, E. et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N. Engl. J. Med. 349, 2483\u20132494 (2003).","journal-title":"N. Engl. J. Med."},{"key":"1203_CR10","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/sj.bjc.6604069","volume":"97","author":"N Lee","year":"2007","unstructured":"Lee, N. et al. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies. Br. J. Cancer 97, 1552\u20131559 (2007).","journal-title":"Br. J. Cancer"},{"key":"1203_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clon.2012.11.004","volume":"25","author":"A Lipton","year":"2013","unstructured":"Lipton, A. et al. Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses. Clin. Oncol. 25, 217\u2013226 (2013).","journal-title":"Clin. Oncol."},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2613.1998.00051.x","volume":"79","author":"LA Kunz-Schughart","year":"1998","unstructured":"Kunz-Schughart, L. A., Kreutz, M. & Knuechel, R. Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int. J. Exp. Pathol. 79, 1\u201323 (1998).","journal-title":"Int. J. Exp. Pathol."},{"key":"1203_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/cbir.1999.0384","volume":"23","author":"LA Kunz-Schughart","year":"1999","unstructured":"Kunz-Schughart, L. A. Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol. Int 23, 157\u2013161 (1999).","journal-title":"Cell Biol. Int"},{"key":"1203_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00689634","volume":"13","author":"RM Hoffman","year":"1994","unstructured":"Hoffman, R. M. The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro? Cancer Metastas. Rev. 13, 169\u2013173 (1994).","journal-title":"Cancer Metastas. Rev."},{"key":"1203_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0022-5347(01)62134-7","volume":"161","author":"L Margolis","year":"1999","unstructured":"Margolis, L. et al. Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor. J. Urol. 161, 290\u2013297 (1999).","journal-title":"J. Urol."},{"key":"1203_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11626-997-0064-8","volume":"33","author":"M Ingram","year":"1997","unstructured":"Ingram, M. et al. Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. Vitr. Cell Dev. Biol. Anim. 33, 459\u2013466 (1997).","journal-title":"Vitr. Cell Dev. Biol. Anim."},{"key":"1203_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrc3507","volume":"13","author":"JL Becker","year":"2013","unstructured":"Becker, J. L. & Souza, G. R. Using space-based investigations to inform cancer research on Earth. Nat. Rev. Cancer 13, 315\u2013327 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1203_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nm0898-901","volume":"4","author":"BR Unsworth","year":"1998","unstructured":"Unsworth, B. R. & Lelkes, P. I. Growing tissues in microgravity. Nat. Med. 4, 901\u2013907 (1998).","journal-title":"Nat. Med."},{"key":"1203_CR19","first-page":"23","volume":"2","author":"A Barzegari","year":"2012","unstructured":"Barzegari, A. & Saei, A. A. An update to space biomedical research: tissue engineering in microgravity bioreactors. Bioimpacts 2, 23\u201332 (2012).","journal-title":"Bioimpacts"},{"key":"1203_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/jcb.10410","volume":"88","author":"C Ontiveros","year":"2003","unstructured":"Ontiveros, C. & McCabe, L. R. Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation. J. Cell. Biochem. 88, 427\u2013437 (2003).","journal-title":"J. Cell. Biochem."},{"key":"1203_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jcb.10120","volume":"85","author":"N Rucci","year":"2002","unstructured":"Rucci, N., Migliaccio, S., Zani, B. M., Taranta, A. & Teti, A. Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV). J. Cell. Biochem. 85, 167\u2013179 (2002).","journal-title":"J. Cell. Biochem."},{"key":"1203_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/1097-4636(200105)55:2<242::AID-JBM1011>3.0.CO;2-D","volume":"55","author":"EA Botchwey","year":"2001","unstructured":"Botchwey, E. A., Pollack, S. R., Levine, E. M. & Laurencin, C. T. Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J. Biomed. Mater. Res. 55, 242\u2013253 (2001).","journal-title":"J. Biomed. Mater. Res."},{"key":"1203_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/154405910508400611","volume":"84","author":"SR Facer","year":"2005","unstructured":"Facer, S. R. et al. Rotary culture enhances pre-osteoblast aggregation and mineralization. J. Dent. Res. 84, 542\u2013547 (2005).","journal-title":"J. Dent. Res."},{"key":"1203_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF02523224","volume":"36","author":"C Granet","year":"1998","unstructured":"Granet, C., Laroche, N., Vico, L., Alexandre, C. & Lafage-Proust, M. H. Rotating-wall vessels, promising bioreactors for osteoblastic cell culture: comparison with other 3D conditions. Med. & Biol. Eng. Comput. 36, 513\u2013519 (1998).","journal-title":"Med. & Biol. Eng. Comput."},{"key":"1203_CR25","first-page":"154","volume":"81","author":"HD Schmidt","year":"2008","unstructured":"Schmidt, H. D. Culture of human stem cells (culture of specialized cells). Yale J. Biol. Med. 81, 154\u2013155 (2008).","journal-title":"Yale J. Biol. Med."},{"key":"1203_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.67","volume":"5","author":"U Krause","year":"2014","unstructured":"Krause, U., Ryan, D. M., Clough, B. H. & Gregory, C. A. An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity. Cell Death Dis. 5, e1093 (2014).","journal-title":"Cell Death Dis."},{"key":"1203_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","volume":"329","author":"CA Gregory","year":"2004","unstructured":"Gregory, C. A., Gunn, W. G., Peister, A. & Prockop, D. J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77\u201384 (2004).","journal-title":"Anal. Biochem."},{"key":"1203_CR28","doi-asserted-by":"publisher","first-page":"132ra155","DOI":"10.1126\/scitranslmed.3003396","volume":"4","author":"S Zeitouni","year":"2012","unstructured":"Zeitouni, S. et al. Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration. Sci. Transl. Med. 4, 132ra155 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1203_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ab.2011.05.032","volume":"416","author":"S Parameswaran","year":"2011","unstructured":"Parameswaran, S. & Verma, R. S. Scanning electron microscopy preparation protocol for differentiated stem cells. Anal. Biochem. 416, 186\u2013190 (2011).","journal-title":"Anal. Biochem."},{"key":"1203_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jbmr.2320","volume":"30","author":"BH Clough","year":"2015","unstructured":"Clough, B. H. et al. Bone regeneration with osteogenically enhanced mesenchymal stem cells and their extracellular matrix proteins. J. Bone Miner. Res. 30, 83\u201394 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"1203_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1\u201313 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1203_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"1203_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1203_CR34","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"1203_CR35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8522","author":"SD Goldstein","year":"2016","unstructured":"Goldstein, S. D., Trucco, M., Guzman, W. B., Hayashi, M. & Loeb, D. M. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.8522 (2016).","journal-title":"Oncotarget"},{"key":"1203_CR36","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1073\/pnas.0914360107","volume":"107","author":"U Krause","year":"2010","unstructured":"Krause, U. et al. Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc. Natl Acad. Sci. USA 107, 4147\u20134152 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1203_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.spinee.2016.10.009","volume":"17","author":"BH Clough","year":"2017","unstructured":"Clough, B. H. et al. An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses. Spine J. 17, 418\u2013430 (2017).","journal-title":"Spine J."},{"key":"1203_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"key":"1203_CR39","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho, E. H. et al. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell Biol. 22, 1172\u20131183 (2002).","journal-title":"Mol. Cell Biol."},{"key":"1203_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0142-9612(01)00137-5","volume":"23","author":"M Borden","year":"2002","unstructured":"Borden, M., Attawia, M., Khan, Y. & Laurencin, C. T. Tissue engineered microsphere-based matrices for bone repair: design and evaluation. Biomaterials 23, 551\u2013559 (2002).","journal-title":"Biomaterials"},{"key":"1203_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/ten.teb.2011.0184","volume":"18","author":"H Wang","year":"2012","unstructured":"Wang, H., Leeuwenburgh, S. C., Li, Y. & Jansen, J. A. The use of micro- and nanospheres as functional components for bone tissue regeneration. Tissue Eng. Part B Rev. 18, 24\u201339 (2012).","journal-title":"Tissue Eng. Part B Rev."},{"issue":"5","key":"1203_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0010-4485(03)00134-9","volume":"36","author":"Pallavi Lal","year":"2004","unstructured":"Lal, P. & Sun, W. Computer Modeling Approach for Microsphere-packed Bone Scaffold. Comput. Aided Des. 36, 487\u2013497 (2004).","journal-title":"Computer-Aided Design"},{"key":"1203_CR43","unstructured":"Gregory, C. A. & Prockop, D. J. in Culture of Human Stem Cells (eds Freshney, R. I., Stacey, G. N. & Auerbach, J. M.) Ch. 9, 208 (Wiley-Liss, Hoboken, NJ, 2007)."},{"key":"1203_CR44","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1089\/ten.tea.2009.0834","volume":"16","author":"D Sheyn","year":"2010","unstructured":"Sheyn, D., Pelled, G., Netanely, D., Domany, E. & Gazit, D. The effect of simulated microgravity on human mesenchymal stem cells cultured in an osteogenic differentiation system: a bioinformatics study. Tissue Eng. Part A 16, 3403\u20133412 (2010).","journal-title":"Tissue Eng. Part A"},{"key":"1203_CR45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/ten.tec.2009.0432","volume":"16","author":"JE Frith","year":"2010","unstructured":"Frith, J. E., Thomson, B. & Genever, P. G. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng. Part C Methods 16, 735\u2013749 (2010).","journal-title":"Tissue Eng. Part C Methods"},{"key":"1203_CR46","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1210\/en.2003-1156","volume":"145","author":"M Zayzafoon","year":"2004","unstructured":"Zayzafoon, M., Gathings, W. E. & McDonald, J. M. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology 145, 2421\u20132432 (2004).","journal-title":"Endocrinology"},{"key":"1203_CR47","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1096\/fasebj.13.9001.s129","volume":"13","author":"G Carmeliet","year":"1999","unstructured":"Carmeliet, G. & Bouillon, R. The effect of microgravity on morphology and gene expression of osteoblasts in vitro. FASEB J. 13, S129\u2013S134 (1999).","journal-title":"FASEB J."},{"key":"1203_CR48","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1359\/jbmr.1997.12.5.786","volume":"12","author":"G Carmeliet","year":"1997","unstructured":"Carmeliet, G., Nys, G. & Bouillon, R. Microgravity reduces the differentiation of human osteoblastic MG-63 cells. J. Bone Miner. Res. 12, 786\u2013794 (1997).","journal-title":"J. Bone Miner. Res."},{"key":"1203_CR49","doi-asserted-by":"publisher","first-page":"139s","DOI":"10.1016\/S8756-3282(98)00007-6","volume":"22","author":"G Carmeliet","year":"1998","unstructured":"Carmeliet, G., Nys, G., Stockmans, I. & Bouillon, R. Gene expression related to the differentiation of osteoblastic cells is altered by microgravity. Bone 22, 139s\u2013143S (1998).","journal-title":"Bone"},{"key":"1203_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.procbio.2017.03.017","volume":"59","author":"J Leber","year":"2017","unstructured":"Leber, J. et al. Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media. Process Biochem. 59, 255\u2013265 (2017).","journal-title":"Process Biochem."},{"key":"1203_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17\u201329 (2002).","journal-title":"Cell"},{"key":"1203_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jcp.20109","volume":"202","author":"R Marom","year":"2005","unstructured":"Marom, R., Shur, I., Solomon, R. & Benayahu, D. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J. Cell. Physiol. 202, 41\u201348 (2005).","journal-title":"J. Cell. Physiol."},{"key":"1203_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0006-291X(02)02951-0","volume":"301","author":"G Bain","year":"2003","unstructured":"Bain, G., Muller, T., Wang, X. & Papkoff, J. Activated beta-catenin induces osteoblast differentiation of C3H10T1\/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301, 84\u201391 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1203_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","volume":"114","author":"M Fulciniti","year":"2009","unstructured":"Fulciniti, M. et al. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma. Blood 114, 371\u2013379 (2009).","journal-title":"Blood"},{"key":"1203_CR55","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1182\/blood-2010-09-308171","volume":"117","author":"WG Gunn","year":"2011","unstructured":"Gunn, W. G., Krause, U., Lee, N. & Gregory, C. A. Pharmaceutical inhibition of glycogen synthetase kinase-3beta reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood 117, 1641\u20131651 (2011).","journal-title":"Blood"},{"key":"1203_CR56","doi-asserted-by":"publisher","first-page":"28067","DOI":"10.1074\/jbc.M300373200","volume":"278","author":"CA Gregory","year":"2003","unstructured":"Gregory, C. A., Singh, H., Perry, A. S. & Prockop, D. J. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem. 278, 28067\u201328078 (2003).","journal-title":"J. Biol. Chem."},{"key":"1203_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass 2nd","year":"2005","unstructured":"Glass, D. A. 2nd et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751\u2013764 (2005).","journal-title":"Dev. Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1203-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:04:03Z","timestamp":1672671843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1203-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1203-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1161"}}